84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Vaccine Adjuvants Market Size and Value to Reach USD USD 3,933.7 Million by 2032 | Growing at CAGR of 13.6%
17 mai 2023 05h21 HE | Market.Us
New York, May 17, 2023 (GLOBE NEWSWIRE) -- The Vaccine Adjuvants Market size reached US$ 1,134.7 Million in 2022. Looking forward, Market.us expects the market to reach US$ 3,933.7 Million by 2032,...
MicrosoftTeams-image (5).png
Polymerase Chain Reaction (PCR) Market to Reach USD 8.1 Bn by 2028, rising at a 6.4% CAGR: TMR Report
04 mai 2023 15h00 HE | Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size stood at US$ 4.1 Bn in 2020 and is expected to surpass US$ 8.1 Bn by...
GMILogo_Vertical-Gradient.png
Pharmaceutical Drug Delivery Market to hit USD 3.2 Trillion by 2032, says Global Market Insights Inc.
03 mai 2023 08h10 HE | Global Market Insights Inc.
Selbyville, Delaware, May 03, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drug delivery market value is predicted to reach over USD 3.2 trillion by 2032, according to a new research report by...
Global Western Blotting Processors Market to Reach USD 1.94 Billion by 2030
25 avr. 2023 19h00 HE | DataM Intelligence
Ohio, Cleveland, April 25, 2023 (GLOBE NEWSWIRE) -- Market Overview: Western blotting is a crucial process for the immunodetection of proteins, specifically proteins that are in low quantity. This...
New Logo.png
Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium (RBS) Against Colistin-Resistant Gram-Negative Bacteria
20 avr. 2023 08h00 HE | Provectus Biopharmaceuticals Inc.
Colistin is used as last-resort treatment for bacterial infectionsProvectus’ RBS effectively inhibits growth of colistin-resistant G- bacteriaRBS also possesses rapid-killing feature KNOXVILLE, TN,...
ILÚM Inform WISCA
Infectious Disease Connect Develops Novel Antibiogram Tool to Improve Empiric Antibiotic Prescribing in Skilled Nursing Facilities
11 avr. 2023 08h00 HE | Infectious Disease Connect
PITTSBURGH, PA, April 11, 2023 (GLOBE NEWSWIRE) -- Researchers from the University of Wisconsin-Madison and the University of Pittsburgh School of Medicine are leading a six-month study to explore...
MicrosoftTeams-image (5).png
Penicillin G Acylase Market to Surpass USD 1.1 Bn Revenue by 2031 | Exclusive Research by TMR
04 avr. 2023 15h30 HE | Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the global penicillin G acylase market was valued at USD...
Icosavax_Logo.jpg
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
30 mars 2023 16h05 HE | Icosavax, Inc.
- FDA granted Fast Track Designation for IVX-A12, a bivalent respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine candidate - - Completed dosing in ongoing Phase 1 study of...
GMILogo_Vertical-Gradient.png
Active Pharmaceutical Ingredients Market to hit USD 453.5 billion by 2032, says Global Market Insights Inc.
20 mars 2023 02h10 HE | Global Market Insights Inc.
Selbyville, Delaware, March 20, 2023 (GLOBE NEWSWIRE) -- Active pharmaceutical ingredients market value is estimated to surpass USD 453.5 billion by 2032, according to a new research report by...
BiondVax LOGO.png
BiondVax to Present at BIO-Europe Spring
16 mars 2023 13h10 HE | BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...